vs
Side-by-side financial comparison of SIFCO INDUSTRIES INC (SIF) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
SIFCO INDUSTRIES INC is the larger business by last-quarter revenue ($24.0M vs $13.7M, roughly 1.8× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs 7.5%, a 68.2% gap on every dollar of revenue. SIFCO INDUSTRIES INC produced more free cash flow last quarter ($8.0M vs $-2.1M).
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
SIF vs XLO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.0M | $13.7M |
| Net Profit | $1.8M | $10.4M |
| Gross Margin | 21.6% | — |
| Operating Margin | 10.7% | -86.5% |
| Net Margin | 7.5% | 75.7% |
| Revenue YoY | 14.8% | — |
| Net Profit YoY | 177.3% | 179.1% |
| EPS (diluted) | $0.29 | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.0M | $13.7M | ||
| Q3 25 | $22.8M | $19.1M | ||
| Q2 25 | $22.1M | $8.1M | ||
| Q1 25 | $19.0M | $2.9M | ||
| Q4 24 | $20.9M | — | ||
| Q3 24 | $21.7M | — | ||
| Q2 24 | $22.0M | — | ||
| Q1 24 | $20.5M | — |
| Q4 25 | $1.8M | $10.4M | ||
| Q3 25 | $-429.0K | $-16.3M | ||
| Q2 25 | $3.4M | $-15.8M | ||
| Q1 25 | $-1.4M | $-13.3M | ||
| Q4 24 | $-2.3M | — | ||
| Q3 24 | $-443.0K | — | ||
| Q2 24 | $72.0K | — | ||
| Q1 24 | $-1.6M | — |
| Q4 25 | 21.6% | — | ||
| Q3 25 | 9.6% | — | ||
| Q2 25 | 26.7% | — | ||
| Q1 25 | 8.3% | — | ||
| Q4 24 | 4.4% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | 12.3% | — | ||
| Q1 24 | 7.3% | — |
| Q4 25 | 10.7% | -86.5% | ||
| Q3 25 | -1.7% | -10.1% | ||
| Q2 25 | 14.8% | -177.7% | ||
| Q1 25 | -4.1% | -472.7% | ||
| Q4 24 | -9.2% | — | ||
| Q3 24 | -1.5% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | -6.5% | — |
| Q4 25 | 7.5% | 75.7% | ||
| Q3 25 | -1.9% | -85.4% | ||
| Q2 25 | 15.4% | -196.0% | ||
| Q1 25 | -7.3% | -452.7% | ||
| Q4 24 | -11.1% | — | ||
| Q3 24 | -2.0% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -7.8% | — |
| Q4 25 | $0.29 | $-3.74 | ||
| Q3 25 | $-0.07 | $-0.11 | ||
| Q2 25 | $0.56 | $-0.16 | ||
| Q1 25 | $-0.23 | $-0.18 | ||
| Q4 24 | $-0.38 | — | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $-0.27 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1M | $137.5M |
| Total DebtLower is stronger | $39.0K | — |
| Stockholders' EquityBook value | $38.7M | $35.3M |
| Total Assets | $74.9M | $154.7M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1M | $137.5M | ||
| Q3 25 | $491.0K | $103.8M | ||
| Q2 25 | $2.0M | $121.6M | ||
| Q1 25 | $1.9M | $89.1M | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $1.7M | — | ||
| Q2 24 | $3.4M | — | ||
| Q1 24 | $2.5M | — |
| Q4 25 | $39.0K | — | ||
| Q3 25 | $51.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $4.1M | — |
| Q4 25 | $38.7M | $35.3M | ||
| Q3 25 | $36.9M | $-8.1M | ||
| Q2 25 | $35.8M | $7.1M | ||
| Q1 25 | $32.4M | $10.7M | ||
| Q4 24 | $33.7M | — | ||
| Q3 24 | $30.4M | — | ||
| Q2 24 | $29.8M | — | ||
| Q1 24 | $29.7M | — |
| Q4 25 | $74.9M | $154.7M | ||
| Q3 25 | $73.4M | $133.7M | ||
| Q2 25 | $77.3M | $133.8M | ||
| Q1 25 | $78.8M | $103.7M | ||
| Q4 24 | $81.0M | — | ||
| Q3 24 | $104.6M | — | ||
| Q2 24 | $106.3M | — | ||
| Q1 24 | $104.2M | — |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.1M | $-2.0M |
| Free Cash FlowOCF − Capex | $8.0M | $-2.1M |
| FCF MarginFCF / Revenue | 33.3% | -15.3% |
| Capex IntensityCapex / Revenue | 0.4% | 0.7% |
| Cash ConversionOCF / Net Profit | 4.51× | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $11.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.1M | $-2.0M | ||
| Q3 25 | $726.0K | $-17.5M | ||
| Q2 25 | $371.0K | $-14.5M | ||
| Q1 25 | $2.8M | $29.0M | ||
| Q4 24 | $-3.8M | — | ||
| Q3 24 | $857.0K | — | ||
| Q2 24 | $382.0K | — | ||
| Q1 24 | $-3.2M | — |
| Q4 25 | $8.0M | $-2.1M | ||
| Q3 25 | $566.0K | — | ||
| Q2 25 | $310.0K | $-14.9M | ||
| Q1 25 | $2.7M | $29.0M | ||
| Q4 24 | $-3.9M | — | ||
| Q3 24 | $580.0K | — | ||
| Q2 24 | $-175.0K | — | ||
| Q1 24 | $-3.9M | — |
| Q4 25 | 33.3% | -15.3% | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 1.4% | -184.0% | ||
| Q1 25 | 14.1% | 988.3% | ||
| Q4 24 | -18.8% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | -0.8% | — | ||
| Q1 24 | -18.9% | — |
| Q4 25 | 0.4% | 0.7% | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 0.3% | 5.0% | ||
| Q1 25 | 0.8% | 0.8% | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.5% | — | ||
| Q1 24 | 3.3% | — |
| Q4 25 | 4.51× | -0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
XLO
Segment breakdown not available.
